Evidence map›Paper›PMID 33452870›Full record

ArticleMolecular genetics & genomic medicine2021

High frequency of the risk allele of rs4132601 and rs11978267 from the IKZF1 gene in indigenous Mexican population.

Jorge Gutiérrez-Franco, Miriam Fabiola Ayón-Pérez, Ma de Jesús Durán-Avelar, Norberto Vibanco-Pérez, Diego Eduardo Sánchez-Jasso, Dulce Guadalupe Bañuelos-Aguayo, Jaime Sánchez-Meza, Helia Judith Pimentel-Gutiérrez, José Francisco Zambrano-Zaragoza, Juan Manuel Agraz-Cibrián and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jorge Gutiérrez-FrancoLaboratorio de Inmunología, Unidad Académica de Ciencias Químico-Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Miriam Fabiola Ayón-PérezLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Ma de Jesús Durán-AvelarLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Norberto Vibanco-PérezLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Diego Eduardo Sánchez-JassoLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Dulce Guadalupe Bañuelos-AguayoLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Jaime Sánchez-MezaLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Helia Judith Pimentel-GutiérrezCharité, Universitätsmedizin, Virchow-Klinikum, Berlin, Germany.
José Francisco Zambrano-ZaragozaLaboratorio de Inmunología, Unidad Académica de Ciencias Químico-Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Juan Manuel Agraz-CibriánLaboratorio de Inmunología, Unidad Académica de Ciencias Químico-Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.
Alejandro Vázquez-ReyesLaboratorios de Investigación en Biología Molecular e Inmunología, Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, Nayarit, México.ORCID 0000-0002-6513-9797
Universidad Autónoma de Nayarit · MXCharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIKZF1 is a relevant gene associated with the pathogenesis of acute lymphoblastic leukemia, and the rs4132601 (T>G) and rs11978267 (A>G) polymorphisms have been associated with the development of this disease in several populations. The aim of this study was to determine the allelic and genotypic frequencies of the rs4132601 and rs11978267 polymorphisms in two indigenous Mexican groups (Cora and Huichol) and Mestizo populations from Nayarit, Mexico, and compare them with the frequencies of both polymorphisms in other populations of the world.

methodsOne hundred, 116, and 100 subjects from the Mestizo, Huichol, and Cora populations, respectively, all of them residents of the state of Nayarit, Mexico, were analyzed. The frequencies of rs4132601 and rs11978267 were determined by allelic discrimination using TaqMan assays.

resultsThe allelic frequencies of rs4132601 were as follows: Mestizo group T = 0.74, G = 0.26; Cora T = 0.745, G = 0.255; and Huichol T = 0.47, G = 0.53. In the case of the rs11978267 polymorphism, the allelic frequencies were Mestizo A = 0.745, G = 0.255; Cora A = 0.735, G = 0.265; and Huichol A = 0.457, G = 0.543. For each population, both polymorphisms were in Hardy-Weinberg equilibrium.

conclusionThe Huichol population from Nayarit presented the highest frequencies of the risk allele reported to date in the whole world for both rs4132601 and rs11978267 polymorphisms.

Indexed as

Gene FrequencyPolymorphism, Single NucleotideAdultFemaleHumansIkaros Transcription FactorIndigenous PeoplesMaleMexicoPrecursor Cell Lymphoblastic Leukemia-LymphomaIkaros Transcription FactorIKZF1 protein, humanALLgenetic polymorphismIKZF1Indigenous Mexican

Identifiers

PMID33452870
PMCPMC8077075
OpenAlexW3124727472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.